These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33861494)

  • 21. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation.
    Cardoso R; Knijnik L; Bhonsale A; Miller J; Nasi G; Rivera M; Blumer V; Calkins H
    Heart Rhythm; 2018 Jan; 15(1):107-115. PubMed ID: 28917562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.
    De Heide J; Vroegh CJ; Bhagwandien RE; Wijchers SA; Szili-Torok T; Zijlstra F; Lenzen MJ; Yap SC
    J Interv Card Electrophysiol; 2018 Dec; 53(3):341-346. PubMed ID: 30074120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
    Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of major bleeding events of uninterrupted non-vitamin K antagonist oral anticoagulants versus uninterrupted vitamin K antagonist during catheter ablation of atrial fibrillation: a meta-analysis of randomised controlled trials.
    Yang Q; Chen X; Zhai J; Dang Y
    Acta Cardiol; 2022 May; 77(3):257-263. PubMed ID: 33871328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of controlled studies on minimally interrupted vs. continuous use of non-vitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation.
    van Vugt SPG; Westra SW; Volleberg RHJA; Hannink G; Nakamura R; de Asmundis C; Chierchia GB; Navarese EP; Brouwer MA
    Europace; 2021 Dec; 23(12):1961-1969. PubMed ID: 34333631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.
    Ukaigwe A; Shrestha P; Karmacharya P; Hussain SK; Samii S; Gonzalez MD; Wolbrette D; Naccarrelli GV
    J Interv Card Electrophysiol; 2017 Mar; 48(2):223-233. PubMed ID: 27771820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan　- Periprocedural and Long-Term Outcomes.
    Nogami A; Soejima K; Morishima I; Hiroshima K; Kato R; Sakagami S; Miura F; Okawa K; Kimura T; Inoue T; Takita A; Uno K; Kumagai K; Kurita T; Gosho M; Aonuma K;
    Circ J; 2022 Dec; 87(1):50-62. PubMed ID: 35989303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periprocedural Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation Without Discontinuation of a Vitamin K Antagonist and Direct Oral Anticoagulants.
    Kojima T; Fujiu K; Fukuma N; Matsunaga H; Oshima T; Matsuda J; Matsubara T; Shimizu Y; Oguri G; Hasumi E; Morita H; Komuro I
    Circ J; 2018 May; 82(6):1552-1557. PubMed ID: 29657252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
    Aoyama D; Miyazaki S; Hasegawa K; Kaseno K; Ishikawa E; Mukai M; Miyahara K; Aiki T; Matsui A; Yamaguchi J; Shiomi Y; Tama N; Ikeda H; Fukuoka Y; Morishita T; Ishida K; Uzui H; Tada H
    Int Heart J; 2019 Nov; 60(6):1315-1320. PubMed ID: 31735780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter ablation in adult congenital heart disease on uninterrupted oral anticoagulation: Is it safe? Data from a large single-center study.
    Foerschner L; Kriesmair J; Telishevska M; Kottmaier M; Bourier F; Reents T; Lengauer S; Lennerz C; Krafft H; Maurer S; Popa M; Kolb C; Deisenhofer I; Hessling G
    Heart Rhythm; 2022 Apr; 19(4):648-655. PubMed ID: 34958942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients.
    Martin AC; Lessire S; Leblanc I; Dincq AS; Philip I; Gouin-Thibault I; Godier A
    Clin Cardiol; 2018 May; 41(5):646-651. PubMed ID: 29532536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.
    Cardoso R; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Brouwer MA; Calkins H
    Clin Cardiol; 2019 Jan; 42(1):198-205. PubMed ID: 30460702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periprocedural Management of Cardiac Tamponade During Catheter Ablation for AF Under Uninterrupted DOAC and Warfarin.
    Yanagisawa S; Inden Y; Ohguchi S; Nagao T; Fujii A; Tomomatsu T; Mamiya K; Okamoto H; Sakamoto Y; Shibata R; Murohara T
    JACC Clin Electrophysiol; 2020 Jul; 6(7):786-795. PubMed ID: 32703560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin.
    Zhao Y; Yang Y; Tang X; Yu X; Zhang L; Xiao H
    J Interv Card Electrophysiol; 2017 Apr; 48(3):267-282. PubMed ID: 28078536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.